LOW vs STRO
Lowe's Companies Inc (LOW) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported LOW revenue for 2026-01-30 was $86.29B. Net income was $6.65B. Revenue was up 3.1% from 2025-01-31 to 2026-01-30. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
LOW currently screens at market cap $121.89B and trailing P/E 18.4. STRO currently screens at market cap $470.8M.
Not investment advice. Open the LOW and STRO stock pages for the full models.
Not investment advice.